Affinity Asset Advisors, LLC Aurinia Pharmaceuticals Inc. Transaction History
Affinity Asset Advisors, LLC
- $579 Million
- Q3 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 175,000 shares of AUPH stock, worth $1.41 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
175,000Holding current value
$1.41 Million% of portfolio
0.35%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AUPH
# of Institutions
208Shares Held
58.6MCall Options Held
1.14MPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$74.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$66.2 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$58.3 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$23.8 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.15B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...